• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于蛋白质生物芯片微阵列技术的全自动心脏多标志物检测策略的分析性能和临床性能

Analytical and clinical performance of a fully automated cardiac multi-markers strategy based on protein biochip microarray technology.

作者信息

Mion Monica M, Novello Enrica, Altinier Sara, Rocco Stefano, Zaninotto Martina, Plebani Mario

机构信息

Department of Laboratory Medicine, University-Hospital of Padova, Via Giustiniani 2, 35128 Padova, Italy.

出版信息

Clin Biochem. 2007 Nov;40(16-17):1245-51. doi: 10.1016/j.clinbiochem.2007.07.018. Epub 2007 Aug 10.

DOI:10.1016/j.clinbiochem.2007.07.018
PMID:17894935
Abstract

OBJECTIVES

The analytical and clinical performance of the Evidence Cardiac Panel were evaluated.

DESIGN AND METHODS

The Evidence Cardiac Panel, an automated protein biochip microarray system, allows the simultaneous determination of creatine kinase MB (CK-MB), myoglobin (MYO), glycogen phosphorylase BB (GPBB), heart-type fatty acid-binding protein (H-FABP), carbonic anhydrase III (CA III), cardiac troponin I (cTnI). Precision: 3 levels of quality control (QC) and 2 in house pools (P) were assayed. Method comparison: MYO and cTnI concentrations measured on Evidence (E) and on Dimension RxL (D) analyzers were compared. Clinical study: 132 non-consecutive patients admitted to the Emergency Department for chest pain were enrolled.

RESULTS AND CONCLUSIONS

The between-day imprecision was CK-MB=6.80-10.08%; MYO=5.36-16.50%; GPBB=6.51-12.12%; H-FABP=6.26-12.63%; CA III=6.98-13.61%; cTnI=6.02-9.80%. Method comparison: E-MYO vs. D-MYO, Bias=-29.22, 95% CI from -40.25 to -18.18; E-cTnI vs. D-cTnI, Bias=-2.75, 95% CI from -4.04 to -1.46. In patients studied (at discharge: AMI, acute myocardial infarction n=42; non-AMI, n=90) H-FABP showed the highest accuracy (ROC analysis, AUC=0.92) and "cTnI+H-FABP" the greatest diagnostic efficacy (89.4%) in AMI diagnosis.

摘要

目的

评估心脏证据检测板的分析性能和临床性能。

设计与方法

心脏证据检测板是一种自动化蛋白质生物芯片微阵列系统,可同时检测肌酸激酶同工酶MB(CK-MB)、肌红蛋白(MYO)、糖原磷酸化酶BB(GPBB)、心脏型脂肪酸结合蛋白(H-FABP)、碳酸酐酶III(CA III)、心肌肌钙蛋白I(cTnI)。精密度:检测3个水平的质量控制(QC)和2个内部样本池(P)。方法比较:比较在心脏证据检测板(E)和Dimension RxL分析仪(D)上测得的MYO和cTnI浓度。临床研究:纳入132例因胸痛入住急诊科的非连续患者。

结果与结论

日间不精密度为CK-MB = 6.80 - 10.08%;MYO = 5.36 - 16.50%;GPBB = 6.51 - 12.12%;H-FABP = 6.26 - 12.63%;CA III = 6.98 - 13.61%;cTnI = 6.02 - 9.80%。方法比较:E-MYO与D-MYO相比,偏差=-29.22,95%置信区间为-40.25至-18.18;E-cTnI与D-cTnI相比,偏差=-2.75,95%置信区间为-4.04至-1.46。在研究的患者中(出院时:急性心肌梗死(AMI)患者n = 42;非AMI患者n = 90),H-FABP在AMI诊断中显示出最高的准确性(ROC分析,曲线下面积(AUC)= 0.92),“cTnI + H-FABP”具有最大的诊断效能(89.4%)。

相似文献

1
Analytical and clinical performance of a fully automated cardiac multi-markers strategy based on protein biochip microarray technology.基于蛋白质生物芯片微阵列技术的全自动心脏多标志物检测策略的分析性能和临床性能
Clin Biochem. 2007 Nov;40(16-17):1245-51. doi: 10.1016/j.clinbiochem.2007.07.018. Epub 2007 Aug 10.
2
Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction.对疑似急性心肌梗死患者进行心脏标志物即时检测分析的评估。
Clin Chim Acta. 2004 Aug 16;346(2):211-9. doi: 10.1016/j.cccn.2004.03.036.
3
Diagnostic accuracy of heart-type fatty acid-binding protein for the early diagnosis of acute myocardial infarction.心脏型脂肪酸结合蛋白对急性心肌梗死早期诊断的准确性。
Am J Emerg Med. 2012 Feb;30(2):267-74. doi: 10.1016/j.ajem.2010.11.022. Epub 2011 Jan 3.
4
[Quantitative analysis of serum troponin I and myoglobin in patients with acute myocardial infarction].急性心肌梗死患者血清肌钙蛋白I和肌红蛋白的定量分析
Di Yi Jun Yi Da Xue Xue Bao. 2005 May;25(5):550-1.
5
Pre-hospital detection of acute myocardial infarction with ultra-rapid human fatty acid-binding protein (H-FABP) immunoassay.采用超快速人脂肪酸结合蛋白(H-FABP)免疫测定法进行急性心肌梗死的院前检测。
Int J Cardiol. 2007 Jul 31;119(3):349-54. doi: 10.1016/j.ijcard.2006.09.003. Epub 2006 Nov 13.
6
[Multi-marker approach in the diagnostics of cardiac diseases by protein biochip technology].[蛋白质生物芯片技术在心脏病诊断中的多标志物方法]
Cas Lek Cesk. 2009;148(12):591-6.
7
Proteomic approach to the diagnosis of acute coronary syndrome: preliminary results.蛋白质组学方法用于急性冠状动脉综合征的诊断:初步结果。
Clin Chim Acta. 2005 Jul 24;357(2):226-35. doi: 10.1016/j.cccn.2005.03.031.
8
Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.心脏型脂肪酸结合蛋白——急性非持续性ST段抬高型冠脉综合征异质性患者群体中心肌坏死的可靠标志物。
Kardiol Pol. 2008 Mar;66(3):253-9, discussion 260-1.
9
Postmortem cardiac troponin I and creatine kinase MB levels in the blood and pericardial fluid as markers of myocardial damage in medicolegal autopsy.法医学尸检中血液和心包液中心脏肌钙蛋白I及肌酸激酶同工酶MB水平作为心肌损伤的标志物
Leg Med (Tokyo). 2007 Sep;9(5):241-50. doi: 10.1016/j.legalmed.2007.01.010. Epub 2007 Apr 24.
10
Serum levels of cardiac troponin I and other marker proteins in patients with chronic renal failure.慢性肾衰竭患者血清中心肌肌钙蛋白I及其他标志物蛋白的水平
Clin Exp Nephrol. 2004 Mar;8(1):43-7. doi: 10.1007/s10157-003-0266-7.

引用本文的文献

1
Brain-Type Glycogen Phosphorylase (PYGB) in the Pathologies of Diseases: A Systematic Review.脑型糖原磷酸化酶 (PYGB) 在疾病病理中的作用:系统评价。
Cells. 2024 Feb 5;13(3):289. doi: 10.3390/cells13030289.
2
New Cardiovascular Biomarkers in Breast Cancer Patients Undergoing Doxorubicin-Based Chemotherapy.接受多柔比星为基础的化疗的乳腺癌患者中的新心血管生物标志物。
Arq Bras Cardiol. 2023 Dec;120(12):e20230167. doi: 10.36660/abc.20230167.
3
Diagnostic accuracy of glycogen phosphorylase BB for myocardial infarction: A systematic review and meta-analysis.
糖原磷酸化酶 BB 对心肌梗死的诊断准确性:系统评价和荟萃分析。
J Clin Lab Anal. 2022 May;36(5):e24368. doi: 10.1002/jcla.24368. Epub 2022 Mar 24.
4
Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis.心脏型脂肪酸结合蛋白(H-FABP)作为急性心肌损伤和缺血后长期预后的生物标志物。
Acta Pharmacol Sin. 2018 Jul;39(7):1155-1163. doi: 10.1038/aps.2018.37. Epub 2018 May 17.
5
Glycogen phosphorylase isoenzyme BB in the diagnosis of acute myocardial infarction: a meta-analysis.糖原磷酸化酶同工酶 BB 在急性心肌梗死诊断中的应用:一项荟萃分析。
Biochem Med (Zagreb). 2013;23(1):78-82. doi: 10.11613/bm.2013.010.
6
Point-of-care test of heart-type fatty acid-binding protein for the diagnosis of early acute myocardial infarction.即时检测心脏型脂肪酸结合蛋白诊断早期急性心肌梗死。
Acta Pharmacol Sin. 2010 Mar;31(3):307-12. doi: 10.1038/aps.2010.2. Epub 2010 Feb 5.